PYFA Australia Pty Ltd entered into a binding scheme implementation deed to acquire remaining 89.67% stake in Probiotec Limited (ASX:PBP) for approximately AUD 240 million on December 21, 2023. The transaction will be financed from combination of debt and direct or indirect equity contributions. The transaction is subject to regulatory approvals, approval by shareholders of PT Pyridam Farma Tbk and Probiotec Limited and court approvals.

The transaction is expected to close on June 30, 2024. Canterbury Partners Pty Ltd acted as financial and Arnold Bloch Leibler and Soewito Suhardiman Eddymurthy Kardono acted as legal advisors to Probiotec Limited. Grant Samuel Group Limited and PT Mandiri Sekuritas acted as financial and Ashurst Australia and Armand, Yapsunto, Muharamsyah & Partners acted as legal advisor to PYFA Australia Pty Ltd. Boardroom Pty Limited acted as registrar to Probiotec Limited.